Jump to Navigation
NASA Audit: Google Founders Received Jet-Fuel Discount
Russian Official Says Nukes Are A Good Response To US...
This Map Shows How Many Countries Contribute To A Single...
IKEA Toy With Name That Translates Into Naughty Word...
How much for F1 star's helmet?
Coffee Prices At This Cafe Vary Depending On How Rude You...
Want to protest at Sochi? There's a zone
Apps to mimic life?
Some Stunning Perspective: China Money Creation Blows US...
Revealed: Best smartphone photos
Emisphere: Crown Jewel In Oral B12
Analyzing Wednesday's Noteworthy Insider Buys And Sells
7 Healthcare Stocks With January Catalysts
Analyzing Friday's Noteworthy Insider Buys And Sells
Novel Cancer Treatment Gains Acceptance
Targeted Chemotherapy: The Perfect Balance Between Safety And Efficacy?
Hyper-Novel Investments For Targeting Cancer
Notable Micro Cap Insider Buys Last Week
Biotechnology And Drug Stocks Up For FDA Approval In August
Delcath Systems 's CEO Discusses Q2 2012 Results - Earnings Call Transcript
Cancer Treatment Need Is The Mother Of Novel Solutions
Delcath Systems: An Exclusive Interview With ROTH Capital Senior Analyst
Interview: Delcath's CEO Provides Details About The Resubmission Of The FDA's New Drug Application For CHEMOSAT
Delcath Systems: A Frustrating Stock With Quite A Bit Of Value Potential
Biotech Weekend Recap: Bears, Bears Everywhere
Delcath Systems Management Discusses Q3 2012 Results - Earnings Call Transcript
Delcath Systems' CEO Presents at Lazard Capital Markets 9th Annual Healthcare Conference (Transcript)
Q3 2012 Pharma Company Updates Indicate Upcoming Catalysts
Three Reasons Delcath Systems Appears Undervalued
Is Delcath The Post-Celsion Play On Liver Cancer?
Cancer Radiation Stocks To Consider: Delcath, Spectrum And IsoRay
The Business Of Cancer
Delcath Systems: 'Improving The Bicycle' In Chemotherapy
Delcath Systems: Bullish On Melblez FDA Panel Vote And Subsequent Approval
US Congress Weighing Budget Compromise
Heart missing after U.S. Marine dies in Greece...
Create new account
Request new password
Click on the icon to sign in with your social network login or enter your Bullfax.com login
EUR/GBP: 1.1879 USD/EUR: 1.3805 JPY/USD: 102.343
Bullfax.com - Market News & Analysis 2008-2011
Terms & Conditions